IGF2BP2 and cancer: The IMP2-ZFAS1-OLA1 axis is instrumental in CRC progression by stabilizing ZFAS1 and enhancing OLA1 activity, which in turn accelerates glycolytic metabolism and supports cancer cell proliferation and survival [97].